並列摘要
Rotavirus is the leading cause of severe diarrhea morbidity in infants and children throughout the world. Rotavirus gastroenteritis should soon be a vaccine-preventable disease. Mortality due to rotavirus intestinal infection is very low; therefore, decision on introduction of mass rotavirus I vaccination will be based on ability of the vaccine to reduce morbidity and the associated health care cost associated with rotavirus infection. However, information of epidemiology of rotavirus infection is rare in Taiwan. The purpose of this study is to review the epidemiology of rotavirusassociated intestinal infection for prevention and intervention efforts.
延伸閱讀
- 洪鼎鈞、廖永樑、楊義爵（2007）。人類輪狀病毒現況與實驗室診斷。內科學誌，18(5)，256-261。https://doi.org/10.6314/JIMT.2007.18(5).04
- 向耀輝、劉清泉、許瑞雲（1981）。人類輪狀病毒感染症。當代醫學，(97)，903-905。https://doi.org/10.29941/MT.198111.0010
- 張弘洋、李宏昌、楊俊仁、黃富源（2000）。輪狀病毒腸胃炎及其疫苗。當代醫學，(319)，373-375。https://doi.org/10.29941/MT.200005.0007
- 徐憶芬、吳奕璋、王春玉（2008）。輪狀病毒疫苗簡介。感染控制雜誌，18(1)，25-32。https://doi.org/10.6526/ICJ.200802_18(1).0003
- Barnes, G. (1998). Rotavirus Vaccines. Acta Paediatrica Sinica, 39(1), 17-20. https://doi.org/10.7097/APS.199802.0017